Databridgemarketresearch.com presents “Tumour Ablation Market expected to worth at CAGR of 8.2% till 2024”, the global tumour ablation market has accounted for USD 1.8 billion in 2016, expected to reach USD 3.5 billion by 2024, growing at a CAGR of 8.2% in the forecast period 2017 to 2024.
- Advertising -
Global Tumour Ablation Market, By Type (Tumour Ablation Systems (Radio Frequency Ablation, Microwave Ablation, HIFU, Laser Ablation, Cryoablation), Image Guidance Products, Accessories), By Cancer Type (Liver, Lings, Kidney, Brain, Bone, Pancreas, Breast, Others), By End-User (Hospitals, Oncology Clinics, Others), By Geography (North America, South America, Europe, Asia-Pacific, Rest of the World) – Trends and Forecast to 2024
The global tumour ablation market is segmented based on product types, cancer types, end-user and geography.
Based on product type the global tumour ablation market is segmented into microwave ablation (coretherm thermotherapy devices and prolieve thermotherapy devices), radiofrequency ablation (RFA) ((temperature controlled devices, fluid cooled, catheter manipulation systems), high intensity focused ultrasound (HIFU), laser ablation and cryoablation. All ablation techniques are percutaneous except HIFU which is administered transcutaneously.
On the basis of cancer types treated using ablation devices the market is segmented into liver, lings, kidney, brain, bone, pancreas, breast and, other cancer types.
- Advertising -
Based on end-user the global tumour ablation market is segmented into hospitals, oncology clinics and others. Oncology clinics is expected to grow at the highest CAGR of 10.9% in the forecast period, owing to development of less time consuming technologies like HIFU increasing in acceptance which will increase the outpatient surgeries which is already trending in global healthcare.
On the basis of geography the global tumour ablation market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. The geographical regions are further segmented into 24 major countries such as U.S., Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.
MAJOR PLAYERS OF THE GLOBAL TUMOUR ABLATION MARKET:
- Galil Medical, Inc.
- Perseon Corporation
- NeuWave Medical, Inc.
- Koninklijke Philips N.V.
- INTIO Inc.
- Mermaid Medical A/S
- SonaCare Medical, LLC
- DFINE, Inc.
- Misonix, Inc.
- BVM Medical Limited
- AngioDynamics, Inc.
- COMSOL Inc.
- Boston Scientific Corporation
- EDAP TMS S.A.
- HealthTronics, Inc.
Browse Full Report: databridgemarketresearch.com/repor…-ablation-market/
Category: Market Research Publishers and RetailersCompany about: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wi ...